Therapeutic targeting of two-pore-domain potassium (K2P) channels in the cardiovascular system

作者: Felix Wiedmann , Constanze Schmidt , Patrick Lugenbiel , Ingo Staudacher , Ann-Kathrin Rahm

DOI: 10.1042/CS20150533

关键词:

摘要: The improvement of treatment strategies in cardiovascular medicine is an ongoing process that requires constant optimization. ability a therapeutic intervention to prevent pathology largely depends on its capacity suppress the underlying mechanisms. Attenuation or reversal disease-specific pathways has emerged as promising paradigm, providing mechanistic rationale for patient-tailored therapy. Two-pore-domain K + (K 2P ) channels conduct outward currents stabilize resting membrane potential and facilitate action repolarization. expression system polymodal current regulation suggest functional significance roles channels. Recent work focused primarily 1.1 [tandem pore domains weak inwardly rectifying channel (TWIK)-1], 2.1 [TWIK-related (TREK)-1], 3.1 acid-sensitive (TASK)-1] their role heart vessels. have been implicated atrial ventricular arrhythmogenesis setting vascular tone. Furthermore, association genetic alterations with fibrillation, cardiac conduction disorders pulmonary arterial hypertension demonstrates relevance disease. function, clinical are summarized present review, options emphasized.

参考文章(90)
M. Fink, F. Duprat, F. Lesage, R. Reyes, G. Romey, C. Heurteaux, M. Lazdunski, Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. The EMBO Journal. ,vol. 15, pp. 6854- 6862 ,(1996) , 10.1002/J.1460-2075.1996.TB01077.X
Claudia Seyler, Patrick A. Schweizer, Edgar Zitron, Hugo A. Katus, Dierk Thomas, Vernakalant activates human cardiac K2P17.1 background K+ channels Biochemical and Biophysical Research Communications. ,vol. 451, pp. 415- 420 ,(2014) , 10.1016/J.BBRC.2014.07.133
Ann-Kathrin Rahm, Jakob Gierten, Jana Kisselbach, Ingo Staudacher, Kathrin Staudacher, Patrick A Schweizer, Rüdiger Becker, Hugo A Katus, Dierk Thomas, PKC‐dependent activation of human K2P18.1 K+ channels British Journal of Pharmacology. ,vol. 166, pp. 764- 773 ,(2012) , 10.1111/J.1476-5381.2011.01813.X
Kathrin Staudacher, Ioana Baldea, Jana Kisselbach, Ingo Staudacher, Ann-Kathrin Rahm, Patrick A. Schweizer, Rüdiger Becker, Hugo A. Katus, Dierk Thomas, Alternative splicing determines mRNA translation initiation and function of human K2P10.1 K+ channels The Journal of Physiology. ,vol. 589, pp. 3709- 3720 ,(2011) , 10.1113/JPHYSIOL.2011.210666
K Staudacher, I Staudacher, E Ficker, C Seyler, J Gierten, J Kisselbach, A-K Rahm, K Trappe, PA Schweizer, R Becker, HA Katus, D Thomas, Carvedilol targets human K2P3.1 (TASK1) K+ leak channels British Journal of Pharmacology. ,vol. 163, pp. 1099- 1110 ,(2011) , 10.1111/J.1476-5381.2011.01319.X
Dina Simkin, Eric J. Cavanaugh, Donghee Kim, Control of the single channel conductance of K2P10.1 (TREK-2) by the amino-terminus: role of alternative translation initiation. The Journal of Physiology. ,vol. 586, pp. 5651- 5663 ,(2008) , 10.1113/JPHYSIOL.2008.161927
Coeli M. B. Lopes, Tibor Rohács, Gábor Czirják, Tamás Balla, Péter Enyedi, Diomedes E. Logothetis, PIP2hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+channels The Journal of Physiology. ,vol. 564, pp. 117- 129 ,(2005) , 10.1113/JPHYSIOL.2004.081935
Constanze Schmidt, Felix Wiedmann, Niels Voigt, Xiao-Bo Zhou, Jordi Heijman, Siegfried Lang, Virginia Albert, Stefan Kallenberger, Arjang Ruhparwar, Gábor Szabó, Klaus Kallenbach, Matthias Karck, Martin Borggrefe, Peter Biliczki, Joachim R. Ehrlich, István Baczkó, Patrick Lugenbiel, Patrick A. Schweizer, Birgit C. Donner, Hugo A. Katus, Dobromir Dobrev, Dierk Thomas, Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation. Circulation. ,vol. 132, pp. 82- 92 ,(2015) , 10.1161/CIRCULATIONAHA.114.012657
C Seyler, E Duthil-Straub, E Zitron, J Gierten, EP Scholz, RHA Fink, CA Karle, R Becker, HA Katus, D Thomas, TASK1 (K2P3.1) K+ channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation British Journal of Pharmacology. ,vol. 165, pp. 1467- 1475 ,(2012) , 10.1111/J.1476-5381.2011.01626.X
Jakob Gierten, David Hassel, Patrick A. Schweizer, Rüdiger Becker, Hugo A. Katus, Dierk Thomas, Identification and functional characterization of zebrafish K2P10.1 (TREK2) two-pore-domain K+ channels Biochimica et Biophysica Acta. ,vol. 1818, pp. 33- 41 ,(2012) , 10.1016/J.BBAMEM.2011.09.015